68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer

Published:2018-09 Issue:9 Volume:43 Page:663-669
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Zang Jie,Mao Feng,Wang Hao,Zhang Jingjing,Liu Qingxing,Peng Li,Li Fang,Lang Lixin,Chen Xiaoyuan,Zhu Zhaohui

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference26 articles.

1. Breast cancer statistics, 2011;CA Cancer J Clin,2011

2. Cancer statistics, 2012;CA Cancer J Clin,2012

3. Age of diagnosis of breast cancer in China: almost 10 years earlier than in the United States and the European Union;Asian Pac J Cancer Prev,2014

4. Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors;Asian Pac J Cancer Prev,2015

5. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation;Cancer Res,1999

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery;ACS Omega;2024-08-15

2. Radiolabeled peptides and their expanding role in clinical imaging and targeted cancer therapy;Journal of Peptide Science;2024-05-06

3. Two Novel [⁶⁸Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar¹¹]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer;ACS Omega;2024-04-10

4. Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review;Seminars in Nuclear Medicine;2024-03

5. Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology;EJNMMI Radiopharmacy and Chemistry;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3